<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03655106</url>
  </required_header>
  <id_info>
    <org_study_id>2018-185</org_study_id>
    <nct_id>NCT03655106</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Catheter Length Survivability</brief_title>
  <official_title>Standard vs Long IV Catheter Long-Term IV Survival Comparison</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>William Beaumont Hospitals</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>William Beaumont Hospitals</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In patients with difficult IV access, ultrasound-guided catheter insertion is a preferred
      technique. However, many peripheral catheters fail and must be replaced, adding extra pain
      and difficulty for the patient, and requiring more healthcare provider time to maintain. In
      preliminary studies, we determined that catheters which extend further into the vein have a
      smaller failure rate. This study will compare two lengths of catheters to see if the longer
      catheters have better survival in a population of patients who have difficult IV access.
      Patients will be randomized to receive a standard length or extra-long venous catheter, which
      will be monitored daily for functionality during the patient's hospital course.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with poor intravenous (IV) access present a daily challenge to emergency department
      (ED) practitioners. Placement of an ultrasound (US)-guided peripheral IV catheter in this
      patient population is a viable and safe option. Ultrasound-guided IVs are often the last
      recourse for IV access before resorting to more invasive procedures in patients with
      difficult access. Successful cannulation with US-guided IV occurs in more than 90% of cases
      compared with 25-35% with traditional IV placement in patients with difficult vascular
      access. Once cannulated, however, the failure rate of IV catheters placed under ultrasound
      guidance is concerning compared with traditional blind IV placement. Overall failure rates
      after successful IV cannulation for US-guided IVs is 45-56% when compared to traditional IV
      placement which is 19-25%. Because failure rate is high, it is important to approach
      insertions methodically to improve survival rates. A variable that may alter the survival of
      US-guided IVs that has not been studied is the length of catheter that resides in the vein.
      Currently the general accepted rule is that an &quot;adequate&quot; amount of the catheter should be in
      the vein to avoid failure of the catheter. Our preliminary data focused on defining this
      relationship. In our study, 100% of catheters failed in which less than 30% of the catheter
      was placed within the vein and no failures in those IVs in which at least 65% of the catheter
      was in the vein. This study was performed by the PI at Beaumont this past year and is
      published in Emergency Medicine Journal.

      This study is a prospective randomized controlled study of catheter longevity comparing a
      4.78 cm (1.88 in) catheter to a longer 6.35 cm (2.5 in) catheter. Subjects will consist of a
      convenience sample of patients with difficult IV access presenting to the Beaumont Hospitals
      emergency department that require US-guided IV access.

      Standard of care is defined as use of a readily available 1.88 inch IV catheter that is used
      daily by emergency department personnel. Following consent, patients will be randomized to
      the control arm using the standard 4.78 cm catheter, or the experimental arm using a 6.35 cm
      catheter. All catheters are 20 gauge in diameter.

      After patient enrollment, the insertion tech, nurse or physician who has been credentialed in
      ultrasound-guided vascular access will place catheters in study subjects. Staff are expected
      to attempt a minimum of 3 attempts before enlisting another provider for help.

      After initial assessment, follow-up functionality of the catheter will be assessed every 24
      hours by the research team as long as the patient is hospitalized, up to 30 days. Function of
      the catheter will be assessed daily by research staff. Function is defined by a catheter's
      ability to draw back 5 ml of blood, flush with 5 ml normal saline without resistance, or if
      IV fluids or medication are continually infusing through the IV.

      Other data variables collected include: patient pertinent medical history, vitals, age, sex,
      cannulation success or failure, vein diameter, length of catheter in vein as well as % length
      of the catheter in the vein, angle of insertion, number of venous access attempts, time to IV
      insertion (tourniquet to tegaderm), location of IV insertion, medications infused or use for
      ionic contrast injection for computed tomography.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 29, 2018</start_date>
  <completion_date type="Actual">July 15, 2019</completion_date>
  <primary_completion_date type="Actual">July 15, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized control parallel assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of IV Survival</measure>
    <time_frame>30 days</time_frame>
    <description>Function is defined by a catheter's ability to draw back 5 ml of blood, flush with 5 ml normal saline without resistance, or if IV fluids or medication are continually infusing through the IV. Function is assessed daily by research staff.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Thrombosis</measure>
    <time_frame>30 days</time_frame>
    <description>Number of patient with thrombosis upper extremity superficial or deep venous thrombosis as measured by venous doppler study in symptomatic patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infection</measure>
    <time_frame>30 days</time_frame>
    <description>Number of patient with infection as defined as the patient meeting the laboratory-confirmed bloodstream infection criteria as defined by the Centers for Disease Control.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">270</enrollment>
  <condition>Catheter Complications</condition>
  <arm_group>
    <arm_group_label>Standard Long IV 4.78 cm 20 g catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Placement of Standard Long IV 4.78 cm 20 g catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultra-Long IV 6.35 cm 20 g catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Placement of Ultra-Long length IV 6.35 cm 20 g catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Long IV 4.78 cm 20 g catheter</intervention_name>
    <description>Standard Long IV 4.78 cm 20 g catheter</description>
    <arm_group_label>Standard Long IV 4.78 cm 20 g catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultra-Long IV 6.35 cm 20 g catheter</intervention_name>
    <description>Ultra-Long IV 6.35 cm 20 g catheter</description>
    <arm_group_label>Ultra-Long IV 6.35 cm 20 g catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Age 18 years or older

        Self-reported difficult IV Access Patient and any one of the following:

          -  Greater than 2 sticks in previous admission/hospital encounter

          -  History of rescue vascular access device (such as US-guided IV, PICC line, midline, or
             CVC)

          -  End-stage renal disease on dialysis

          -  History of IV Drug Use

          -  History of Sickle Cell Disease

        Exclusion Criteria:

        Age under 18 years old

          -  Voluntary withdrawal or refusal to participate

          -  Previous enrollment into the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amit Bahl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Director of Emergency Ultrasound</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beaumont Hospitals</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>August 29, 2018</study_first_submitted>
  <study_first_submitted_qc>August 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <results_first_submitted>February 26, 2020</results_first_submitted>
  <results_first_submitted_qc>February 26, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">March 11, 2020</results_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>William Beaumont Hospitals</investigator_affiliation>
    <investigator_full_name>Amit Bahl</investigator_full_name>
    <investigator_title>Director of Emergency Ultrasound</investigator_title>
  </responsible_party>
  <keyword>Ultrasound guided intravenous access</keyword>
  <keyword>vascular access</keyword>
  <keyword>extended dwell catheter</keyword>
  <keyword>IV survival</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 19, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/06/NCT03655106/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Long IV 4.78 cm 20 g Catheter</title>
          <description>Placement of Standard Long IV 4.78 cm 20 g catheter
Standard Long IV 4.78 cm 20 g catheter: Standard Long IV 4.78 cm 20 g catheter</description>
        </group>
        <group group_id="P2">
          <title>Ultra-Long IV 6.35 cm 20 g Catheter</title>
          <description>Placement of Ultra-Long length IV 6.35 cm 20 g catheter
Ultra-Long IV 6.35 cm 20 g catheter: Ultra-Long IV 6.35 cm 20 g catheter</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="135"/>
                <participants group_id="P2" count="135"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="126"/>
                <participants group_id="P2" count="131"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Duplicate Enrollment</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Long IV 4.78 cm 20 g Catheter</title>
          <description>Placement of Standard Long IV 4.78 cm 20 g catheter
Standard Long IV 4.78 cm 20 g catheter: Standard Long IV 4.78 cm 20 g catheter</description>
        </group>
        <group group_id="B2">
          <title>Ultra-Long IV 6.35 cm 20 g Catheter</title>
          <description>Placement of Ultra-Long length IV 6.35 cm 20 g catheter
Ultra-Long IV 6.35 cm 20 g catheter: Ultra-Long IV 6.35 cm 20 g catheter</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="126"/>
            <count group_id="B2" value="131"/>
            <count group_id="B3" value="257"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="126"/>
                    <count group_id="B2" value="131"/>
                    <count group_id="B3" value="257"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.2" spread="18.6"/>
                    <measurement group_id="B2" value="60.2" spread="18.2"/>
                    <measurement group_id="B3" value="59.2" spread="17.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="126"/>
                    <count group_id="B2" value="131"/>
                    <count group_id="B3" value="257"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="92"/>
                    <measurement group_id="B2" value="92"/>
                    <measurement group_id="B3" value="184"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="126"/>
                    <count group_id="B2" value="131"/>
                    <count group_id="B3" value="257"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="131"/>
                    <measurement group_id="B3" value="257"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Duration of IV Survival</title>
        <description>Function is defined by a catheter's ability to draw back 5 ml of blood, flush with 5 ml normal saline without resistance, or if IV fluids or medication are continually infusing through the IV. Function is assessed daily by research staff.</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Long IV 4.78 cm 20 g Catheter</title>
            <description>Placement of Standard Long IV 4.78 cm 20 g catheter
Standard Long IV 4.78 cm 20 g catheter: Standard Long IV 4.78 cm 20 g catheter</description>
          </group>
          <group group_id="O2">
            <title>Ultra-Long IV 6.35 cm 20 g Catheter</title>
            <description>Placement of Ultra-Long length IV 6.35 cm 20 g catheter
Ultra-Long IV 6.35 cm 20 g catheter: Ultra-Long IV 6.35 cm 20 g catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of IV Survival</title>
          <description>Function is defined by a catheter's ability to draw back 5 ml of blood, flush with 5 ml normal saline without resistance, or if IV fluids or medication are continually infusing through the IV. Function is assessed daily by research staff.</description>
          <units>hours</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="71" upper_limit="120"/>
                    <measurement group_id="O2" value="136" lower_limit="116" upper_limit="311"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Thrombosis</title>
        <description>Number of patient with thrombosis upper extremity superficial or deep venous thrombosis as measured by venous doppler study in symptomatic patients</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Long IV 4.78 cm 20 g Catheter</title>
            <description>Placement of Standard Long IV 4.78 cm 20 g catheter
Standard Long IV 4.78 cm 20 g catheter: Standard Long IV 4.78 cm 20 g catheter</description>
          </group>
          <group group_id="O2">
            <title>Ultra-Long IV 6.35 cm 20 g Catheter</title>
            <description>Placement of Ultra-Long length IV 6.35 cm 20 g catheter
Ultra-Long IV 6.35 cm 20 g catheter: Ultra-Long IV 6.35 cm 20 g catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Thrombosis</title>
          <description>Number of patient with thrombosis upper extremity superficial or deep venous thrombosis as measured by venous doppler study in symptomatic patients</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Infection</title>
        <description>Number of patient with infection as defined as the patient meeting the laboratory-confirmed bloodstream infection criteria as defined by the Centers for Disease Control.</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Long IV 4.78 cm 20 g Catheter</title>
            <description>Placement of Standard Long IV 4.78 cm 20 g catheter
Standard Long IV 4.78 cm 20 g catheter: Standard Long IV 4.78 cm 20 g catheter</description>
          </group>
          <group group_id="O2">
            <title>Ultra-Long IV 6.35 cm 20 g Catheter</title>
            <description>Placement of Ultra-Long length IV 6.35 cm 20 g catheter
Ultra-Long IV 6.35 cm 20 g catheter: Ultra-Long IV 6.35 cm 20 g catheter</description>
          </group>
        </group_list>
        <measure>
          <title>Infection</title>
          <description>Number of patient with infection as defined as the patient meeting the laboratory-confirmed bloodstream infection criteria as defined by the Centers for Disease Control.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="126"/>
                <count group_id="O2" value="131"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 Days post IV catheter insertion</time_frame>
      <desc>Thrombosis was assessed based on upper extremity venous duplex results in symptomatic patients.
Catheter related bloodstream infection was determined by the institutional Department of Epidemiology based on the definition of catheter related bloodstream infection provided by the Centers of Disease Control.</desc>
      <group_list>
        <group group_id="E1">
          <title>Standard Long IV 4.78 cm 20 g Catheter</title>
          <description>Placement of Standard Long IV 4.78 cm 20 g catheter
Standard Long IV 4.78 cm 20 g catheter: Standard Long IV 4.78 cm 20 g catheter</description>
        </group>
        <group group_id="E2">
          <title>Ultra-Long IV 6.35 cm 20 g Catheter</title>
          <description>Placement of Ultra-Long length IV 6.35 cm 20 g catheter
Ultra-Long IV 6.35 cm 20 g catheter: Ultra-Long IV 6.35 cm 20 g catheter</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="131"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="126"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="131"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Amit Bahl, MD</name_or_title>
      <organization>William Beaumont Hospitals</organization>
      <phone>2488982245</phone>
      <email>amit.bahl@beaumont.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

